Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
U.S. Gun Violence Rates Jumped 30% During PandemicMandates, Not Recommendations, Work Best to Get Folks Vaccinated: StudyU.S. Has Shared 200 Million Shots With Other CountriesLittle Change Seen in Americans' Use of Mental Health Services During PandemicWomen Doctors Face Higher Levels of Harassment, Frustration: SurveyEPA Plans New Strategy Against PFAS 'Forever Chemicals'State Spending on Poverty Really Pays Off for Kids: StudyState Lotteries Didn't Help Boost Vaccination RatesVaccinated Foreign Travelers Can Enter United States Beginning Nov. 8Despite Pressures of Pandemic, U.S. Nursing School Enrollment ClimbsBiden Administration to Invest $100 Million to Ease Health Worker ShortageFDA Warns Against Using At-Home Dermal Filler 'Pens'Death Threats, Trolling Common for Scientists Who Speak to Media About COVID'Extreme Heat' Days Have Tripled Since 1980s, and More Are ComingAHA News: Are Monolingual Spanish Speakers More at Risk in the Pandemic?Your Free Cancer Screen Shows Trouble: What If You Can't Afford the Follow-Up?Bystanders Can Make the Difference for a Drowning ChildClimate Change is World's Most Pressing Health Problem: WHOAHA News: Another Barrier for Black and Hispanic People: Good Mental Health CareU.S. to Buy $1 Billion Worth of Rapid COVID TestsNearly 200,000 COVID Home Tests Recalled Over False PositivesMedical Mistrust Fuels Vaccine Hesitancy Among HispanicsAmericans Divided on Biden's Vaccine Mandate, Poll FindsAir Pollution Linked to 6 Million Premature Births in 1 YearDelay in Graphic Warning Labels on Cigarettes Cost Lives: StudyAHA News: Women May Be More Willing Than Men to Donate OrgansEPA to Sharply Limit Refrigerant Production in New Climate RuleAHA News: Food Insecurity's Long-Term Health ConsequencesU.S. to Buy 500 Million More COVID Vaccine Doses for Global DonationNIH Spending Nearly $470 Million on Long-Haul COVID StudyCOVAX Cuts Global COVID Vaccine Supply Estimates By a QuarterFDA Bans Sale of Nearly a Million E-Cigarettes; Allows Juul to Remain on MarketMore Affordable Housing, Healthier Hearts?Biden to Strengthen Push for Vaccine Mandates in New COVID PlanU.S. COVID Vaccination Rates Climb in AugustGreener Neighborhoods Bring Healthier Hearts, Study ShowsU.S. to Be Removed From E.U. Safe Travel ListFDA Tells Three Small E-Cigarette Makers to Stop Selling Flavored ProductsFratelli Beretta Antipasto Trays Are the Source of Salmonella Outbreak: CDCHow Your Medicines Make Their Way Into Rivers, Lakes and BaysFamily Behind Oxycontin Denies Any Responsibility for Opioid CrisisCommon Pesticide to Be Banned Over Links to  Problems in ChildrenFar Too Few People of Color in U.S. Pancreatic Cancer TrialsRace-Based Disparities in Americans' Health Haven't Improved: StudyChild Injuries, Deaths Spur Recall of 10 Million Magnet Balls, CubesAmericans Have High Trust in Health Care Providers: PollBreaded, Raw Chicken Recalled in Multi-State Salmonella OutbreakU.S. Military Members Must Get COVID Vaccine by Mid-September6 Tips on Getting Back to Your Regular Doctor's CheckupNursing Home Staff Closest to Patients Are Least Likely to Get COVID Vaccines
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

U.S. to Buy $1 Billion Worth of Rapid COVID Tests

HealthDay News
by Robert Preidt and Robin Foster
Updated: Oct 6th 2021

new article illustration

WEDNESDAY, Oct. 6, 2021 (HealthDay News) -- The Biden administration said Wednesday that it plans to purchase $1 billion worth of rapid, at-home coronavirus tests and take other actions to quadruple the number of tests available to Americans by December.

By the end of the year, the number of at-home tests should increase to 200 million a month, according to the White House, which will also expand the number of pharmacies in the federal government's free testing program to 20,000, an administration official told the Washington Post.

Increasing access to rapid tests is long overdue, public health experts said.

"This is a big deal," Scott Becker, chief executive officer of the Association of Public Health Laboratories, told the Post. "The White House is beginning to take testing as seriously as they've taken vaccinations."

In recent months, many Americans have reported difficulty getting testing appointments or buying at-home tests, according to the Post.

"These tests are cheap to make -- and there's a lot of demand for it out there," Dr. Ashish Jha, dean of the Brown University School of Public Health, told the Post. "The reason the market hasn't worked is because the [U.S. Food and Drug Administration] has made it very difficult for these tests to get out into the marketplace."

One testing advocate said approvals of rapid tests are not coming fast enough.

"This slow trickle of [emergency authorizations] is all but promising to get us a large supply of rapid tests just in time for them to no longer be as effective against Delta," Dr. Michael Mina, a Harvard University epidemiologist who has advocated for at-home testing, told the Post. "There are amazing tests produced in the billions that simply don't exist here in the U.S."

FDA officials have said they are concerned that the rapid tests are less accurate than the slower PCR tests that need to be evaluated in a laboratory and can take days to produce results. On Wednesday, the Australian company Ellume recalled roughly 195,000 of its at-home coronavirus rapid tests after discovering an increased chance that the affected kits would return false positive results.

More information

Visit the U.S. Food and Drug Administration for more on COVID testing.

SOURCE: Washington Post




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net